- Home
- MSM vs CRNX Comparison
MSM vs CRNX Comparison
Compare MSM & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSM | CRNX |
|---|---|---|
| Founded | 1941 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.1B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MSM | CRNX |
|---|---|---|
| Price | $87.18 | $48.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $91.25 | $71.00 |
| AVG Volume (30 Days) | 589.9K | ★ 1.0M |
| Earning Date | 01-07-2026 | 11-06-2025 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.57 | N/A |
| Revenue | ★ $3,769,521,000.00 | $1,535,000.00 |
| Revenue This Year | $6.46 | $425.41 |
| Revenue Next Year | $5.08 | $943.30 |
| P/E Ratio | $24.38 | ★ N/A |
| Revenue Growth | N/A | ★ 47.74 |
| 52 Week Low | $68.10 | $24.10 |
| 52 Week High | $94.31 | $54.78 |
Technical Indicators
Market Signals| Indicator | MSM | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 54.80 | 54.95 |
| Support Level | $86.56 | $43.04 |
| Resistance Level | $87.56 | $49.61 |
| Average True Range (ATR) | 1.67 | 2.04 |
| MACD | 0.33 | -0.16 |
| Stochastic Oscillator | 79.74 | 63.35 |
Price Performance
Historical ComparisonAbout MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.